Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
TENOCYCLIDINE
ID: ALA279676
Max Phase: Phase
Molecular Formula: C15H23NS
Molecular Weight: 249.42
Molecule Type: Small molecule
Associated Items:
ID: ALA279676
Max Phase: Phase
Molecular Formula: C15H23NS
Molecular Weight: 249.42
Molecule Type: Small molecule
Associated Items:
Synonyms (5): 2-thienyl analog of phencyclidine | Tenocyclidine | Thienylcyclidine | Thienylphencyclidine | Thiophene analog of phencyclidine
Synonyms from Alternative Forms(5):
Canonical SMILES: c1csc(C2(N3CCCCC3)CCCCC2)c1
Standard InChI: InChI=1S/C15H23NS/c1-3-9-15(10-4-1,14-8-7-13-17-14)16-11-5-2-6-12-16/h7-8,13H,1-6,9-12H2
Standard InChI Key: JUZZEWSCNBCFRL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 249.42 | Molecular Weight (Monoisotopic): 249.1551 | AlogP: 4.39 | #Rotatable Bonds: 2 |
Polar Surface Area: 3.24 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.15 | CX LogP: 4.40 | CX LogD: 1.72 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.75 | Np Likeness Score: -0.68 |
1. Gray NM, Cheng BK, Mick SJ, Lair CM, Contreras PC.. (1989) Phencyclidine-like effects of tetrahydroisoquinolines and related compounds., 32 (6): [PMID:2542555] [10.1021/jm00126a016] |
2. Kimes AS, Wilson AA, Scheffel U, Campbell BG, London ED.. (1992) Radiosynthesis, cerebral distribution, and binding of [125I]-1-(p-iodophenyl)-3-(1-adamantyl)guanidine, a ligand for sigma binding sites., 35 (25): [PMID:1469697] [10.1021/jm00103a005] |
3. PubChem BioAssay data set, |
4. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
5. TOMIZAWA M, OTSUKA H, MIYAMOTO T, YAMAMOTO I. (1995) Pharmacological Effects of Imidacloprid and Its Related Compounds on the Nicotinic Acetyicholine Receptor with Its Ion Channel from the Torpedo Electric Organ, 20 (1): [10.1584/jpestics.20.49] |
6. TOMIZAWA M, OTSUKA H, MIYAMOTO T, ELDEFRAWI ME, YAMAMOTO I. (1995) Pharmacological Characteristics of Insect Nicotinic Acetyicholine Receptor with Its Ion Channel and the Comparison of the Effect of Nicotinoids and Neonicotinoids, 20 (1): [10.1584/jpestics.20.57] |
7. PubChem BioAssay data set, |
Source(3):